T1	p 44 67	inclusion body myositis
T2	p 216 256	44 patients with inclusion body myositis
T3	i 90 115	methotrexate or placebo .
T4	i 159 176	oral methotrexate
T5	i 286 304	placebo-controlled
T6	i 525 537	methotrexate
T7	i 553 560	placebo
T8	i 840 852	methotrexate
T9	i 878 895	oral methotrexate
T10	o 20 40	weakness progression
T11	o 54 67	body myositis
T12	o 248 256	myositis
T13	o 332 389	change of quantitative muscle strength testing sum scores
T14	o 430 477	Quantitative muscle strength testing sum scores
T15	o 660 729	manual muscle testing sum scores , activity scale scores and patients
T16	o 736 747	assessments
T17	o 778 808	Serum creatine kinase activity
T18	o 929 944	muscle weakness
T19	o 959 989	serum creatine kinase activity